Thứ Bảy, 20 tháng 12, 2014

Health Law Events at January 2015 AALS Annual Meeting


   Health Law Events at
the
January 2015 AALS Annual Meeting










































Friday, JAN. 2


6:30 pm - 8:30 pm





Lebanese Taverna


2641 Connecticut NW





Health Law
Professors Reception
 


Drinks & heavy
hors d'oeuvres






Saturday, JAN. 3


10:30 am - 12:15 pm





Marriott Park
Wardman


Maryland Suite A
Lobby Level





Competition Policy
in Health Care


Section on Antitrust
& Economic Regulation


Co-sponsored by
Section on Law, Medicine & Health Care





Competition in
health care is a fundamental issue to a better functioning health care system
that benefits consumers. The panel will discuss some of the most exciting issues
in the interface between the two areas: competition between for profits and
not for profits, hospital mergers, anti-competitive state licensing and other
forms of state action, reverse payments in pharmaceuticals, integration
through ACOs or merger, and contractual relations between payers and
providers.





Panelists:


·        
Thomas L. Greaney, Saint Louis University School of Law


·        
Rebecca Haw, Vanderbilt University Law School


·        
Kristin M. Madison, Northeastern University School of Law


·        
Ann Marie Marciarille, University of Missouri-Kansas City
School of Law


·        
Hillary Greene, University of Connecticut School of Law
(moderator)





Saturday, JAN. 3


12:30 pm - 2:30 pm





Omni Shoreham Hotel


Diplomat Ballroom
Lobby Level





Lunch Debate:
Resolved, that the Affordable Care Act


Does Not Authorize
Subsidies for Individuals Purchasing


Health Insurance
Through Federal Exchanges





Speakers:


·        
Jonathan Adler, Case Western
University School of Law


·        
Nicholas Bagley, University of
Michigan School of Law





Saturday, JAN. 3


1:30 pm - 3:15 pm





Marriott Park
Wardman


Wilson C


Mezzanine Level





An Examination of
Patient Dumping by Hospitals after Thirty Years of EMTALA


Section on Law &
Mental Disability


Co-sponsored by
Section on Law, Medicine & Health Care





The Emergency
Medical Treatment and Active Labor Act of 1986 (EMTALA) was designed to
ensure equal access to emergency treatment by hospitals and to stop the
practice of “patient dumping.” Patient dumping occurs when patients needing
emergency care – typically uninsured, disabled, and minority individuals –
are transferred, prematurely discharged, or are denied treatment altogether.
Thirty years after EMTALA was passed, patient dumping is still occurring. And
healthcare delivery has changed dramatically, with stunning advances in
medical science and the advent of major, national movements toward evidence-based
medicine care and systems-based quality improvement.





Have these sweeping changes
left EMTALA behind, so out of touch with current practice that it is now
harming, rather than helping, equal access to emergency care? What impact
will the Affordable Care Act have on EMTALA? What impact is EMTALA having on
the push for community-based services, the growing use of telemedicine,
medical repatriation and the number of the mentally disabled in prisons? This
panel will address these questions and others while analyzing a forthcoming
report of the U.S. Commission on Civil Rights on EMTALA. The panel will also
share teaching materials on covering EMTALA in doctrinal courses.





Panelists:


·        
Martin R. Castro, Chair, U.S. Commission on Civil Rights,
Washington, D.C.


·        
Richard L. Elliott, Ph.D., Professor and Director of
Professionalism and Medical Ethics,


·        
Mercer University School of Medicine, Macon, GA


·        
Katharine A. Van Tassel, University of Akron, C. Blake
McDowell Law Center


·        
Hernan Vera, President and Chief Executive Officer, Public
Counsel, Los Angeles, CA


·        
Barry Kozak, The John Marshall Law School (moderator)





Saturday, JAN. 3


3:30 pm - 5:15 pm





Marriott Park
Wardman


Washington 5


Exhibition Level





Unbefriended
Elderly: Making Medical Treatment Decisions for Patients without Surrogates


Section on Law,
Medicine & Health Care


Joint Program with
Section on Aging & Law





You are an
orthopedic surgeon. Tomorrow morning, you are scheduled to fix an elderly woman’s
broken hip. But the woman is demented, and no family can be located. Do you
proceed? Or do you seek a court-appointed guardian to give you the “go
ahead”? Delaying surgery increases the risks of complications.  But proceeding means acting without authorization
or informed consent.  Would your
answers change if the woman has a caring nephew who is not recognized as a
valid surrogate under your state's health care decision making statute?





Unfortunately,
clinicians and facilities across the United States have responded to these
questions in inconsistent and ad hoc ways. 
This is troubling, because the “unbefriended” or “unrepresented” are
some of the most powerless and marginalized members of society.  They comprise 3-4% of the 1.3 million
people living in nursing homes and 5% of the 500,000 per year who die in
ICUs.





These expert
panelists will describe the scope and nature of the problem as well as its
causal factors.  They will also outline
both currently implemented and proposed solutions.





Panelists:


·        
Ellen Fox, MD - President and CEO at Integrated Ethics
Consulting LLC; formerly Chief Officer, Ethics in Health Care, Department of
Veterans Affairs


·        
Sharona Hoffman, JD, LLM - Case Western Reserve University
School of Law


·        
Rebecca C. Morgan, JD - Stetson University College of Law


·        
David Orentlicher, MD, JD - Indiana University Robert H.
McKinney School of Law


·        
Erica F. Wood, JD - Assistant Director, ABA Commission on Law
and Aging





There will be a section
business meeting at the end of this session.





Saturday, JAN. 3


5:15 pm - 6:30 pm





Marriott
Park Wardman


Mckinley


Mezzanine
Level





Health Law Works in
Progress for New Law Teachers


Section on Law,
Medicine & Health Care





Four junior health
law scholars were invited through a competitive selection process.  Their papers have already been
distributed.  At the meeting, each will
briefly present her/his papers in a separate and concurrent roundtable
setting (though two will share a single roundtable).  Then, senior scholars will provide oral
comments and critiques.  Some will also
provide written feedback on the manuscript. 
The author of each paper will be given an opportunity to respond and
ask questions of his or her own.  The
goal of the workshop is to improve the work before publication.  This new program also presents an
opportunity for the audience to hear cutting edge health law scholarship by
recent members of the academy.





Authors:


·        
Zack Buck, JD - Mercer University Walter F. George School of
Law:  “State Anti-Fraud Statutes, Off-Label Marketing, and the
Solvable Challenge of Causation”


·        
Christine S. Ho, JD, MPP - Rutgers School of Law –
Newark:  “The Exception that Undermines the Rule: An Examination of the
Nameless Threat of Underinclusion in Health Law"


·        
David Kwok, JD, MPP, PhD - University of Houston Law
Center:  “Fair Competition and False Claims in Off-Label Marketing”


·        
Katherine T. Vukadin, JD - Texas Southern University Thurgood
Marshall School of Law:  “Obamacare Interrupted: Obstructive Federalism
and the Consumer Information Blockade”





Commentators:


·        
Jennifer Bard


·        
Gregg Bloche


·        
Robert A. Bohrer


·        
Kathleen Boozang *


·        
Leslie Francis


·        
Abbe Gluck


·        
Mark Hall


·        
Nan Hunter


·        
Joan Krause *


·        
Kristin Madison


·        
Gwen Majette


·        
David Orentlicher *


·        
Frank Pasquale


·        
Thaddeus Pope


·        
Ani Satz


·        
Sidney Watson *


Sunday, JAN. 4


4:00 pm - 5:45 pm





Marriott
Park Wardman


Maryland Suite C


Lobby Level





Tort Law and a
Healthier Society


(Section on Torts
& Compensation Systems)





The section will
present a program on leading issues at the intersection of tort and health law.
Professor Mello will discuss medical malpractice alternatives for hospitals.
Professor Reiss will discuss liability issues related to vaccine-preventable
diseases. Professor Winters will discuss food safety impact litigation. The
section will also honor the winner of its annual William L. Prosser Award for
outstanding contribution in scholarship, teaching, and service related to
tort law.





Panelists:


·        
Michelle Mello, Stanford Law School


·        
Dorit Reiss, University of California, Hastings College of the
Law


·        
Diana Winters, Indiana University Robert H. McKinney School of
Law


·        
Andrew R. Klein, Indiana University Robert H. McKinney School
of Law (moderator)





Monday, JAN. 5


10:30 am - 12:15 pm





Marriott
Park Wardman


Virginia Suite A


Lobby Level





Ebola and the Law


(Section on Biolaw)





The 2014 West
African outbreak of the Ebola virus is the most severe epidemic attributed to
this pathogen since 1976, when international health officials began keeping
records on Ebola. As of August 2014, the total number of suspected cases has
approached 2,000 and the number of suspected deaths has exceeded 1,000. The
World Health Organization has


designated the
health crisis as one of international concern. The law has a strong stake in containing
this outbreak and preventing future episodes of this kind.  The section invited papers addressing
issues of law and policy arising from the Ebola outbreak. Issues may include
(but by no means were limited to) the following:


·        
Why was the international legal and public health community so
slow to recognize the 2014 Ebola outbreak? Human beings are supremely attuned
to threats posed by other humans (such as war or terrorism), but far less
prepared for threats deemed “natural” or “environmental.” How should law
accommodate and/or offset this biological predisposition?


·        
There is no vaccine or cure for Ebola. Medicines for treating
Ebola, carrying some hope of reducing the mortality rate, are in extremely
short supply. What are the bioethical implications raised by the decision to
devote the extremely limited supplies of Ebola medication — no more than a
handful of doses as of August 2014 — to medical workers of non-African
origin? How should the U.S. Food and Drug Administration and its foreign
counterparts handle petitions to expedite the experimental use of Ebola
medication?


                                        


Panelists:


·        
Robert A. Bohrer, California Western School of Law


·        
Lan Cao, Chapman University Dale E. Fowler School of Law


·        
Carl H. Coleman, Seton Hall University School of Law


·        
Victoria Sutton, Texas Tech University School of Law


·        
James Ming Chen, Michigan State University College of Law
(moderator)


·        
Andrew W. Torrance, University of Kansas School of Law
(commentator)


·        
Katharine A. Van Tassel, University of Akron, C. Blake
McDowell Law Center (commentator)













0 nhận xét:

Đăng nhận xét